NeuroPace, Inc. (NPCE)
16.78
+0.51
(+3.13%)
USD |
NASDAQ |
Dec 10, 16:00
16.76
-0.02
(-0.12%)
After-Hours: 20:00
NeuroPace Profit Margin (Quarterly): -12.78% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Standard BioTools, Inc. | -162.0% |
| LENSAR, Inc. | -25.94% |
| Intelligent Bio Solutions, Inc. | -269.4% |
| Adagio Medical Holdings, Inc. | -- |
| Movano, Inc. | -5.04K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -149.8% |
| Return on Assets | -23.31% |
| Return on Invested Capital | -27.09% |
| Gross Profit Margin (Quarterly) | 77.39% |
| Operating Margin (Quarterly) | -9.50% |
| Return on Net Operating Assets | -58.65% |